Company intelligence / Profile preview

Prospection

Sydney, New South Wales, Australia

Ownership: Private
Employees: ~79
Development stage: Commercial

Overview

Prospection provides advanced patient-centric intelligence platforms that enable pharmaceutical companies to analyze real-world patient journeys at scale. Their solutions help optimize drug performance and improve patient outcomes by informing commercial strategy with deep insights into care pathways. The company’s technology supports over 100 clinical indications in more than 20 therapeutic areas and serves top global pharma brands. No direct clinical trial results as the company does not develop therapeutics.

Therapeutic areas: Other
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Works with more than 100 life sciences customers including top 25+ pharmaceutical companies globally; specific partners not named publicly

Beyond the preview

Go deeper on Prospection.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prospection.

Explore the full profile